"The introduction of innovative technology into cross-border capital investment" investment model has won high praise from governments all over China!
Infinity Capital Management Co., Ltd. is one of the top 500 Chinese enterprises and the equity investment platform of Huafa Group, a leading state-owned enterprise in Zhuhai. It is an internationally renowned investment management institution with state-owned enterprises and Israeli characteristic resources. As the earliest Sino-foreign cooperative venture capital fund in China, Infinity won the first business license of the non-legal person Sino-foreign cooperative venture capital fund issued by the Chinese government. The founder, Mr. Amir Gal-Or, won the Chinese Government Friendship Award issued by the State Council Office, which is also the highest honor award given by the Chinese government to foreign experts working in China. Infinity Capital has offices in 12 cities across China, covering the five major business areas, North China, East China, South China, Southwest, Hong Kong as well as overseas.
At present, the investment fund of Infinity in China has more than 8 billion RMB invested in TMT (science and technology, media, communications), health and life sciences, energy conservation and environmental protection, advanced manufacturing and new materials and other areas of the key layout. In the last two years, Infinity Capital has had Ten successful listings: Vincent Medical (HK01612), AsymChem (002821), Huati Technology (603679), Liancheng Precision (002921),Lihu Booster (300694), BlueSword (688557), Xin Feng Guang (688663), Triductor Technology (688259), SmartGiant (688115), and Hinova (688302). Hongtu Separator and IOPtima have been acquired by Jinguan Electrical (300510), Kanghong Pharmaceutical (002773) respectively which has achieved good results. Additionally, at present, a number of portfolio companies are preparing to IPO.